YDES — YD Bio Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro Cap

Annual balance sheet for YD Bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS
Standards:	USG	USG	USG
Status:	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	0.043	0.096	3.14
Net Total Accounts Receivable
Net Total Receivables	0.038	0.098	0.263
Total Inventory
Prepaid Expenses
Total Current Assets	0.127	0.272	3.47
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.06	0.014	0.088
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	0.227	0.321	6.86
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	0.17	0.298	0.263
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	0.217	0.298	0.274
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	0.009	0.023	6.59
Total Liabilities & Shareholders' Equity	0.227	0.321	6.86
Total Common Shares Outstanding